SynteractHCR, a full-service, international CRO, is the recipient of five 2016 CRO Leadership Awards from Life Science Leader magazine. For the 2016 CRO Leadership Awards, Life Science Leader magazine teamed up with Industry Standard Research (ISR) to develop a benchmarking survey, taken by biopharma clients, which would determine the award recipients.
More than 65 CROs were assessed for 27 performance metrics in the survey. Survey respondents were recruited from pharma and biopharma companies of all sizes and were screened for decision-making influence related to working with CROs within the past 18 months; 2,200 service encounters were captured. This level of qualification ensures that survey responses are based on actual involvement with CROs and clear experiential data.
Life Science Leader established five core categories: capabilities, compatibility, expertise, quality and reliability. To win, customers must have judged the CROs as top performers or as exceeding expectations. CROs could win in up to three groupings—big pharma, small pharma or overall, which combined the scores from both big and small pharma. SynteractHCR won in the following categories:
Compatibility (Overall)
Capabilities (Big Pharma)
Compatibility (Big Pharma)
Expertise (Big Pharma)
Quality (Big Pharma)
Ed Miseta, executive editor for Life Science Leader, said, “The winners were decided by looking at 27 different performance metrics, as rated by decision-making executives at biopharmaceutical companies. The CROs receiving an award this year are truly at the top of their class, and are deserving of the recognition they receive. Being a top performer in any of these categories shows expertise and commitment to clinical trials and serving the needs of biopharmaceutical companies and their patients.”
This is the second time that SynteractHCR has been honored with Life Science Leader CRO awards. In 2015, SynteractHCR won in the emerging pharma category for innovation, reliability, productivity and regulatory expertise.
